Marijuana in the management of amyotrophic lateral sclerosis

@article{Carter2001MarijuanaIT,
  title={Marijuana in the management of amyotrophic lateral sclerosis},
  author={Gregory T Carter and B S Rosen},
  journal={American Journal of Hospice and Palliative Medicine},
  year={2001},
  volume={18},
  pages={264 - 270}
}
  • G. Carter, B. S. Rosen
  • Published 1 July 2001
  • Psychology
  • American Journal of Hospice and Palliative Medicine
Marijuana has been proposed as treatment for a widening spectrum of medical conditions. Marijuana is a substance with many properties that may be applicable to the management of amyotrophic lateral sclerosis (ALS). These include analgesia, muscle relaxation, bronchodilation, saliva reduction, appetite stimulation, and sleep induction. In addition, marijuana has now been shown to have strong antioxidative and neuroprotective effects, which may prolong neuronal cell survival. In areas where it is… 

Tables from this paper

Survey of cannabis use in patients with amyotrophic lateral sclerosis

TLDR
Results indicate that cannabis may be moderately effective at reducing symptoms of appetite loss, depression, pain, spasticity, and drooling and ineffective in reducing difficulties with speech and swallowing, and sexual dysfunction.

Medical marijuana: emerging applications for the management of neurologic disorders.

  • G. CarterV. Ugalde
  • Medicine
    Physical medicine and rehabilitation clinics of North America
  • 2004

Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis?

TLDR
A short but important overview of evidences that are useful to better characterize the efficacy as well as the molecular pathways modulated by cannabinoids are provided.

Cannabis and Amyotrophic Lateral Sclerosis: Hypothetical and Practical Applications, and a Call for Clinical Trials

TLDR
Based on the currently available scientific data, it is reasonable to think that cannabis might significantly slow the progression of ALS, potentially extending life expectancy and substantially reducing the overall burden of the disease.

Current pharmacological management of amyotropic lateral sclerosis and a role for rational polypharmacy

TLDR
Based on the available data, it is the opinion that combination drug therapies should be considered for future clinical trials.

Pharmacologic Approaches to the Treatment of Amyotrophic Lateral Sclerosis

TLDR
Gene transfer of VEGF or glial cell-line derived neurotrophic factor, anti-inflammatory COX-2 inhibitors, and minocycline have had particularly promising results in mice.

Cannabis therapy in neurological disorders: Recent advances and perspectives

TLDR
Although there are clinical studies supporting the use of cannabis preparations as adjuvant therapy in neurological disorders, more investigations are needed to assess their safety and efficacy.

Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders

TLDR
There is insufficient evidence to support the recommendation of medical marijuana for the treatment of the most common medical and psychological conditions for which it has been allowed at the state level.

PHARMACOTHERAPY OF AMYOTROPHIC LATERAL SCLEROSIS: AN INSIGHT

TLDR
Current therapeutic approaches including recent advances in pharmacological treatment strategies along with nutrition and dietary supplements based on the potential to delay onset of disease, retard the progression of Disease, extend the lifespan and improve the quality of life of patients are reviewed.
...

References

SHOWING 1-10 OF 76 REFERENCES

Marijuana: medical implications.

TLDR
Adverse effects from marijuana use include decreased coordination, epithelial damage to the lungs, increased risk of infection, cardiovascular effects and cognitive deficits.

Medicinal marijuana: a comprehensive review.

TLDR
A comprehensive literature review of the topic found that patients who are best suited to medicinal marijuana will be those who will gain substantial benefit to offset these risks, and who have failed a well-documented, compliant and comprehensive approach to standard therapies.

Comprehensive management of amyotrophic lateral sclerosis.

  • G. CarterR. Miller
  • Medicine, Psychology
    Physical medicine and rehabilitation clinics of North America
  • 1998

Expanding the role of hospice care in amyotrophic lateral sclerosis

TLDR
There is a great need to increase awareness of both patients and clinicians regarding the effectiveness of hospice in the care of advanced ALS patients, because hospice services are far underutilized in this setting.

Health aspects of cannabis.

Marijuana, receptors and immunomodulation.

TLDR
It has recently been shown that THC can enhance production or release of pro-inflammatory cytokines, including augmented release of IL1, TNF alpha, and IL6 activity.

Endocannabinoids and vascular function.

  • C. Hillard
  • Biology, Chemistry
    The Journal of pharmacology and experimental therapeutics
  • 2000
TLDR
Two arachidonic acid analogs, N-arachidonylethanolamine and 2-arACHidonylglycerol are hypothesized to function as endogenous ligands of the CB(1) receptor, and they are the subjects of this review.

Recent clinical experience with dronabinol

Medicinal Uses of Marijuana

TLDR
This purported review of the literature clearly supports continued listing of crude marijuana on schedule 1, while allowing its synthetic analogue, Marinol, to be legally prescribed on schedule 2, and Voth and Schwartz's perspective on medicinal use of marijuana is significant.
...